Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

NCT03011008 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Autoimmune Diabetes

Interventions

DRUG: Liraglutide
DRUG: Insulin

Sponsor

Second Xiangya Hospital of Central South University